Alverine-Loaded Lipid Bilayer–Graphene Oxide Hybrids as a Novel Nanomedicine Platform for Neural Cancer
International Journal of Molecular Sciences · 04.04.2026 · 27 (7) · 3273
DOI: 10.3390/ijms27073273 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.04.2026. Verfasst von Alicja Przybylska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Technology and Engineering, Poznan University of Technology, Berdychowo 4, 60-965 Poznan, Poland. Hauptthemen laut MEDLINE: Graphite, Neuroblastoma, Lipid Bilayers, Nanomedicine. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, MUR, University of Catania.
Abstract (Originalsprache)
Graphene oxide (GO)–lipid hybrid nanostructures represent a promising class of multifunctional platforms for drug delivery and fluorescence-guided cellular imaging. In this study, we developed a graphene oxide-supported lipid bilayer system composed of rhodamine-labeled phosphatidylcholine (POPC-Rhod) for the delivery of the repurposed antispasmodic drug alverine citrate (ALV) to neuroblastoma cells. The hybrid nanostructures were assembled using two drug-loading strategies and characterized by UV–Vis spectroscopy, fluorescence analysis, dynamic light scattering, and atomic force microscopy to evaluate molecular interactions, vesicle size distribution, and nanomechanical properties. In vitro studies were performed using human neuroblastoma SH-SY5Y cells and their retinoic acid-differentiated neuronal-like counterparts. Confocal microscopy confirmed efficient cellular uptake of the fluorescent lipid–graphene hybrids, while viability and mitochondrial reactive oxygen species assays revealed differentiation-dependent cellular responses. ALV-loaded hybrids induced cytotoxic effects in proliferating neuroblastoma cells, whereas differentiated neuron-like cells exhibited greater tolerance and, at moderate concentrations, preserved viability despite increased oxidative stress. These findings demonstrate that graphene oxide–lipid hybrids can act as fluorescence-traceable drug delivery platforms and highlight the potential of alverine as a candidate for repurposing in neural cancer models. The system presented here provides a proof-of-concept framework for the development of multifunctional nanocarriers integrating therapeutic delivery with imaging capabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Technology and Engineering, Poznan University of Technology, Berdychowo 4, 60-965 Poznan, Poland.
- Institute of Crystallography, National Council of Research (IC-CNR), via Paolo Gaifami, 18, 95126 Catania, Italy.
- Nano Hybrid Biointerfaces Laboratory (NHBIL), Department of Chemical Sciences, University of Catania, viale Andrea Doria, 6, 95125 Catania, Italy.
ORCID-Profile: Alicja Przybylska, Irina Naletova, Katarzyna Dopierała, Agnieszka Kołodziejczak-Radzimska, Cristina Satriano
Förderung
- European Union
- MUR
- University of Catania
- Ministry of Science and Higher Education
Zitieren
APA
Przybylska, A., Naletova, I., Attanasio, F., Dopierała, K., Kołodziejczak-Radzimska, A., & Satriano, C. (2026). Alverine-Loaded Lipid Bilayer–Graphene Oxide Hybrids as a Novel Nanomedicine Platform for Neural Cancer. International Journal of Molecular Sciences, 27(7), 3273. https://doi.org/10.3390/ijms27073273
Vancouver
Przybylska A, Naletova I, Attanasio F, Dopierała K, Kołodziejczak-Radzimska A, Satriano C. Alverine-Loaded Lipid Bilayer–Graphene Oxide Hybrids as a Novel Nanomedicine Platform for Neural Cancer. International Journal of Molecular Sciences. 2026;27(7):3273. doi:10.3390/ijms27073273
BibTeX
@article{Przybylska2026,
author = {Przybylska, Alicja and Naletova, Irina and Attanasio, Francesco and Dopierała, Katarzyna and Kołodziejczak-Radzimska, Agnieszka and Satriano, Cristina},
title = {Alverine-Loaded Lipid Bilayer–Graphene Oxide Hybrids as a Novel Nanomedicine Platform for Neural Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3273},
doi = {10.3390/ijms27073273}
}
EUVIMED